The International Treatment Preparedness Coalition (ITPC) released its Annual report 2016: Investing in Communities.
To access a summary, click here.
[gview file="http://ecuo.org/mvdev/wp-content/uploads/sites/4/2017/05/ITPC-Annual-Review-2016.pdf"]
Source
Harm Reduction International released a report, Harm reduction investment in the European Union: Current spending, challenges and successes ahead of the 25th Harm Reduction International Conference (HR17) taking place on 14 – 17 May 2017 in Montréal, Canada.
[gview file="http://ecuo.org/mvdev/wp-content/uploads/sites/4/2017/05/HRWreportApril2017_web_1.pdf"]
[gview file="http://ecuo.org/mvdev/wp-content/uploads/sites/4/2017/05/thepolicy2017_online_version.pdf"]
Europe is the birthplace of harm ...
The European Medicines Agency’s (EMA) 2016 annual report published today focuses on the Agency’s key achievements in the areas of medicine evaluation, support to research and development of new and innovative treatments and the safety monitoring of medicines in real life.
In 2016, the Agency recommended ...
Recurrent TB and associated factors: A five-year countrywide study in Uzbekistan
Abstract
Background
In Uzbekistan, despite stable and relatively high tuberculosis treatment success rates, relatively high rates of recurrent tuberculosis have recently been reported. Recurrent tuberculosis is when a patient who was treated for pulmonary tuberculosis and cured, ...
Treatment Action Group and the ACTION Global Health Advocacy Partnership will host a 2-part webinar series on civil society asks and engagement ahead of the Global Ministerial Conference on TB to be held on 16–17 November 2017 in Moscow, Russian Federation.
The two webinars will take ...
Over the next 20 years, cases of drug-resistant tuberculosis (TB) are set to rise in India, the Philippines, Russia, and South Africa – the four countries which already bear the highest burden.
A new study published in The Lancet Infectious Diseases says the rise is likely ...
Antiretroviral therapy (ART) has increased life expectancy by a decade in young Europeans and North Americans treated for HIV. Substantial declines in mortality emerged especially for those starting treatment between 2008 and 2010, pointing to the positive effect of evolving therapies and earlier detection.
Reporting in ...
This year, pre-exposure prophylaxis (PrEP) advocates noted a stunning disconnect between key organizations that issue guidelines on the use of tenofovir/emtricitabine (TDF/FTC, Truvada) for HIV prevention: The United States Centers for Disease Control and Prevention (CDC) continues to say that people need 20 days of ...
DR-TB STAT and the Sentinel Project will host a webinar, MDR-TB Treatment with Bedaquiline in Children and Adolescents: Global Recommendations and Program Experience in Belarus on 26 May 2017.
For more information about the webinar and how to connect, click here.
Source
Research at the University of Illinois at Urbana-Champaign has provided the first evidence that viruses and hosts share highly similar regulatory sequences in their promoters—the initiation sequences of human genes that code for functional proteins.
“To date viral-host networks include protein and mRNA interactions between viruses ...
AIDS data contains the very latest data, from the end of 2015 and in mid-2016, on the world’s response to HIV: the latest information on the number of people living with HIV, the number of new HIV infections, the numbers of people—both adults and children—on ...
The Global Fund has issued a new request for 2 proposals to select civil society service providers to support the realisation of 2 components of the Community Rights and Gender Strategic Initiative, during 2017-2019:
Civil society and community organizations to provide peer-to-peer short-term technical assistance for civil ...